263 related articles for article (PubMed ID: 22456426)
21. [Breast implants and anaplastic large cell lymphoma: What do we know?].
Mychaluk J; Perignon D; Qassemyar Q; Gianfermi M; Sinna R
Ann Chir Plast Esthet; 2012 Feb; 57(1):1-8. PubMed ID: 22243720
[TBL] [Abstract][Full Text] [Related]
22. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
23. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.
Fryzek JP; Ye W; Nyrén O; Tarone RE; Lipworth L; McLaughlin JK
Breast Cancer Res Treat; 2006 May; 97(2):131-4. PubMed ID: 16328720
[TBL] [Abstract][Full Text] [Related]
24. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
25. Age-related lobular involution and risk of breast cancer.
Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
28. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study.
Lipworth L; Tarone RE; Friis S; Ye W; Olsen JH; Nyren O; McLaughlin JK
Int J Cancer; 2009 Jan; 124(2):490-3. PubMed ID: 19003966
[TBL] [Abstract][Full Text] [Related]
29. Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option.
De Silva IM; Teague JA; Blake WE
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1773-6. PubMed ID: 23751975
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature.
Wong AK; Lopategui J; Clancy S; Kulber D; Bose S
Am J Surg Pathol; 2008 Aug; 32(8):1265-8. PubMed ID: 18594466
[TBL] [Abstract][Full Text] [Related]
31. Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
Ramos-Gallardo G; Cuenca-Pardo J; Rodríguez-Olivares E; Iribarren-Moreno R; Contreras-Bulnes L; Vallarta-Rodríguez A; Kalixto-Sanchez M; Hernández C; Ceja-Martinez R; Torres-Rivero C
J Invest Surg; 2017 Feb; 30(1):56-65. PubMed ID: 27537783
[TBL] [Abstract][Full Text] [Related]
32. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
33. Breast augmentation: a risk factor for breast cancer?
Berkel H; Birdsell DC; Jenkins H
N Engl J Med; 1992 Jun; 326(25):1649-53. PubMed ID: 1588977
[TBL] [Abstract][Full Text] [Related]
34. How Common Is Breast Implant-Associated Anaplastic Large Cell Lymphoma? First Four Cases in Israel.
Ben Naftali Y; Barnea Y; Clemens MW; Bar-Meir E
Isr Med Assoc J; 2019 Aug; 21(8):512-515. PubMed ID: 31474008
[TBL] [Abstract][Full Text] [Related]
35. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence.
Ye X; Shokrollahi K; Rozen WM; Conyers R; Wright P; Kenner L; Turner SD; Whitaker IS
Mutat Res Rev Mutat Res; 2014; 762():123-32. PubMed ID: 25475421
[TBL] [Abstract][Full Text] [Related]
37. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
Wolfe F; Michaud K
Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
[TBL] [Abstract][Full Text] [Related]
38. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants.
Locke MB; Lofts J
ANZ J Surg; 2017 Oct; 87(10):789-794. PubMed ID: 25827224
[TBL] [Abstract][Full Text] [Related]
39. Incidence of right-sided colorectal cancer after breast cancer: a population-based study.
Tang LY; Nugent Z; Demers AA; Singh H
Am J Gastroenterol; 2009 May; 104(5):1213-20. PubMed ID: 19319130
[TBL] [Abstract][Full Text] [Related]
40. Anaplastic large cell lymphoma in the setting of textured breast implant: a call for patients and physicians education.
Zakhary JM; Hamidian Jahromi A; Chaudhery S; Kim M
J La State Med Soc; 2013; 165(1):26-9. PubMed ID: 23550394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
